|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang PM, Chou CJ, Tseng SH and Hung CF:
Bioinformatics and in vitro experimental analyses identify
the selective therapeutic potential of interferon gamma and
apigenin against cervical squamous cell carcinoma and
adenocarcinoma. Oncotarget. 8:46145–46162. 2017.PubMed/NCBI
|
|
3
|
zur Hausen H: Papillomaviruses and cancer:
From basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schiffman M, Castle PE, Jeronimo J,
Rodriguez AC and Wacholder S: Human papillomavirus and cervical
cancer. Lancet. 370:890–907. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Burd EM: Human papillomavirus and cervical
cancer. Clin Microbiol Rev. 16:1–17. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hildesheim A, Gonzalez P, Kreimer AR,
Wacholder S, Schussler J, Rodriguez AC, Porras C, Schiffman M,
Sidawy M, Schiller JT, et al: Impact of human papillomavirus (HPV)
16 and 18 vaccination on prevalent infections and rates of cervical
lesions after excisional treatment. Am J Obstet Gynecol.
215:212.e1–212.e15. 2016. View Article : Google Scholar
|
|
7
|
Galic V, Herzog TJ, Lewin SN, Neugut AI,
Burke WM, Lu YS, Hershman DL and Wright JD: Prognostic significance
of adenocarcinoma histology in women with cervical cancer. Gynecol
Oncol. 125:287–291. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cancer Genome Atlas Research Network:
Integrated genomic and molecular characterization of cervical
cancer. Nature. 543:378–384. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
del Pilar Camacho-Leal M, Sciortino M and
Cabodi S: ErbB2 receptor in breast cancer: Implications in cancer
cell migration, invasion and resistance to targeted therapy. Breast
Cancer Biol Med. 2017. View
Article : Google Scholar
|
|
10
|
Shi H, Gong H, Cao K, Zou S, Zhu B, Bao H,
Wu Y, Gao Y, Tang Y and Yu R: Nrdp1-mediated ErbB3 degradation
inhibits glioma cell migration and invasion by reducing cytoplasmic
localization of p27(Kip1). J Neurooncol. 124:357–364. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-delta delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yan X, Chen X, Liang H, Deng T, Chen W,
Zhang S, Liu M, Gao X, Liu Y, Zhao C, et al: miR-143 and miR-145
synergistically regulate ERBB3 to suppress cell proliferation and
invasion in breast cancer. Mol Cancer. 13:2202014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Michael N, Hopkins M and Jura N: Mechanism
of PI3K activation by the HER3/ErbB3 receptor. 2016.
|
|
14
|
Lyu H, Huang J, Edgerton SM, Thor AD and
Liu B: Abstract B20: Role of ErbB3 in tumorigenesis and drug
resistance in ErbB2-driven breast cancer. 2015. View Article : Google Scholar
|
|
15
|
Ma J, Lyu H, Huang J and Liu B: Targeting
of erbB3 receptor to overcome resistance in cancer treatment. Mol
Cancer. 13:1052014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Davies S, Holmes A, Lomo L, Steinkamp MP,
Kang H, Muller CY and Wilson BS: High incidence of ErbB3, ErbB4 and
MET expression In ovarian cancer. Int J Gynecol Pathol. 33:4022014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Castellsagué X: Natural history and
epidemiology of HPV infection and cervical cancer. Gynecol Oncol.
110:S4–S7. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schiffman M and Wentzensen N: Human
papillomavirus infection and the multistage carcinogenesis of
cervical cancer. Cancer Epidemiol Biomarkers Prev. 22:553–560.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sollome JJ, Thavathiru E, Camenisch TD and
Vaillancourt RR: HER2/HER3 regulates extracellular acidification
and cell migration through MTK1 (MEKK4). Cell Signal. 26:70–82.
2014. View Article : Google Scholar : PubMed/NCBI
|
